The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement
Open accessAbstract
For kinase inhibitors, intracellular target selectivity is fundamental to pharmacological mechanism. Although a number of acellular techniques have been developed to measure kinase binding or enzymatic inhibition, such approaches can fail to accurately predict engagement in cells. Here we report the application of an energy transfer technique that enabled the first broad-spectrum, equilibrium-based approach to quantitatively profile target occupancy and compound affinity in live cells. Using this method, we performed a selectivity profiling for clinically relevant kinase inhibitors against 178 full-length kinases, and a mechanistic interrogation of the potency offsets observed between cellular and biochemical analysis. For the multikinase inhibitor crizotinib, our approach accurately predicted cellular potency and revealed improved target selectivity compared with biochemical measurements. Due to cellular ATP, a number of putative crizotinib targets are unexpectedly disengaged in live cells at a clinically relevant drug dose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Comprehensive analysis of kinase inhibitor selectivity
Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., & Zarrinkar, P. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1990 · Cited by 2,409
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Identification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059 · cited 1×
“It has been previously established that both nec-1 and GNF-2 are functionally competitive with ATP (Iacob et al., 2011; Degterev et al., 2008), consistent with our ability to detect their kinase interactions using type I, ATP-competitive energy transfer probes.”
BackgroundTracking cancer drugs in living cells by thermal profiling of the proteome
Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., et al. (2014) · Science · doi:10.1126/science.1255784 · Cited by 1,187 · cited 3×
“CETSA is also reportedly prone to a number of noteworthy false-negative results for multikinase inhibitors, limiting its utility in the context of broad kinome profiling (Savitski et al., 2014).”
BackgroundInfluentialImamura, H., Huynh Nhat, K. P., Togawa, H., Saito, K., Iino, R., Kato-Yamada, Y., Nagai, T., & Noji, H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904764106 · Cited by 1,101
Cui, J. J., Tran-Dubé, M., Shen, H., Nambu, M., Kung, P.-P., Pairish, M., Jia, L., Meng, J., Funk, L., Botrous, I., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2007613 · Cited by 932
The promise and peril of chemical probes
Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1867 · Cited by 839
Self-citationLigand binding assays at equilibrium: validation and interpretation
Hulme, E. C., & Trevethick, M. A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00604.x · Cited by 657
Features of Selective Kinase Inhibitors
Knight, Z. A., & Shokat, K. M. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.04.011 · Cited by 657
Marroquin, L. D., Hynes, J., Dykens, J. A., Jamieson, J. D., & Will, Y. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm052 · Cited by 628
Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
Zhang, J., Adrián, F. J., Jahnke, W., Cowan-Jacob, S. W., Li, A. G., Iacob, R. E., Sim, T., Powers, J., Dierks, C., Sun, F., et al. (2010) · Nature · doi:10.1038/nature08675 · Cited by 597
Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
Wu, P., Nielsen, T. E., & Clausen, M. H. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.008 · Cited by 457
Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes
Zhao, Q., Ouyang, X., Wan, X., Gajiwala, K. S., Kath, J. C., Jones, L. H., Burlingame, A. L., & Taunton, J. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b08536 · Cited by 388
Mammalian endoplasmic reticulum stress sensor IRE1 signals by dynamic clustering
Li, H., Korennykh, A. V., Behrman, S. L., & Walter, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010580107 · Cited by 357
Comprehensive characterization of the Published Kinase Inhibitor Set
Elkins, J. M., Fedele, V., Szklarz, M., Abdul Azeez, K. R., Salah, E., Mikolajczyk, J., Romanov, S., Sepetov, N., Huang, X.-P., Roth, B. L., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3374 · Cited by 323
Self-citationTarget engagement and drug residence time can be observed in living cells with BRET
Robers, M. B., Dart, M. L., Woodroofe, C. C., Zimprich, C. A., Kirkland, T. A., Machleidt, T., Kupcho, K. R., Levin, S., Hartnett, J. R., Zimmerman, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms10091 · Cited by 274
Self-citationMeasuring and interpreting the selectivity of protein kinase inhibitors
Smyth, L. A., & Collins, I. (2009) · Journal of Chemical Biology · doi:10.1007/s12154-009-0023-9 · Cited by 197
A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
Fauster, A., Rebsamen, M., Huber, K. V. M., Bigenzahn, J. W., Stukalov, A., Lardeau, C.-H., Scorzoni, S., Bruckner, M., Gridling, M., Parapatics, K., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.130 · Cited by 188
Self-citationNuclear Localization of p38 MAPK in Response to DNA Damage
Wood, C. D., Thornton, T. M., Sabio, G., Davis, R. A., & Rincon, M. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.428 · Cited by 169
Phase II Study of Dasatinib in Patients With Advanced Non–Small-Cell Lung Cancer
Johnson, F. M., Bekele, B. N., Feng, L., Wistuba, I., Tang, X. M., Tran, H. T., Erasmus, J. J., Hwang, L.-L., Takebe, N., Blumenschein, G. R., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5474 · Cited by 166
Progress towards a public chemogenomic set for protein kinases and a call for contributions
Drewry, D. H., Wells, C. I., Andrews, D. M., Angell, R. M., Al‐Ali, H., Axtman, A. D., Capuzzi, S. J., Elkins, J. M., Ettmayer, P., Frederiksen, M. U., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181585 · Cited by 161
Self-citationCrystal Structure of the MuSK Tyrosine Kinase
Till, J. H., Becerra, M., Watty, A., Lu, Y., Ma, Y., Neubert, T. A., Burden, S. J., & Hubbard, S. R. (2002) · Structure · doi:10.1016/s0969-2126(02)00814-6 · Cited by 150
Optimized Chemical Proteomics Assay for Kinase Inhibitor Profiling
Médard, G., Pachl, F., Ruprecht, B., Klaeger, S., Heinzlmeir, S., Helm, D., Qiao, H., Ku, X., Wilhelm, M., Kuehne, T., et al. (2015) · Journal of Proteome Research · doi:10.1021/pr5012608 · Cited by 142
Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors
Ross‐Macdonald, P., de Silva, H., Guo, Q. J., Xiao, H., Hung, C.-Y., Penhallow, B. A., Markwalder, J. A., He, L., Attar, R. M., Lin, T.-A., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0826 · Cited by 135
Wodicka, L. M., Ciceri, P., Davis, M. I., Hunt, J. P., Floyd, M. B., Salerno, S. N., Hua, X. H., Ford, J. M., Armstrong, R. C., Zarrinkar, P. P., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.09.010 · Cited by 134
Förster, M., Chaikuad, A., Bauer, S. M., Holstein, J., Robers, M. B., Corona, C. R., Gehringer, M., Pfaffenrot, E., Ghoreschi, K., Knapp, S., et al. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.10.008 · Cited by 133
Self-citationKlutchko, S. R., Hamby, J. M., Boschelli, D. H., Wu, Z., Kraker, A. J., Amar, A. M., Hartl, B. G., Shen, C., Klohs, W. D., Steinkampf, R. W., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9802259 · Cited by 130
Non-ATP Competitive Protein Kinase Inhibitors
Garuti, L., Roberti, M., & Bottegoni, G. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791859333 · Cited by 128
Affinity Profiling of the Cellular Kinome for the Nucleotide Cofactors ATP, ADP, and GTP
Becher, I., Savitski, M. M., Savitski, M. F., Hopf, C., Bantscheff, M., & Drewes, G. (2012) · ACS Chemical Biology · doi:10.1021/cb3005879 · Cited by 100
Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα
Nacht, M., Qiao, L., Sheets, M. P., Martin, T. S., Labenski, M., Mazdiyasni, H., Karp, R., Zhu, Z., Chaturvedi, P., Bhavsar, D., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3008745 · Cited by 90
Tuning a Three-Component Reaction For Trapping Kinase Substrate Complexes
Statsuk, A. V., Maly, D. J., Seeliger, M. A., Fabian, M. A., Biggs, W., Lockhart, D. J., Zarrinkar, P. P., Kuriyan, J., & Shokat, K. M. (2008) · Journal of the American Chemical Society · doi:10.1021/ja807066f · Cited by 75
A Type-II Kinase Inhibitor Capable of Inhibiting the T315I “Gatekeeper” Mutant of Bcr-Abl
Choi, H. G., Ren, P., Adrián, F., Sun, F., Lee, H. S., Wang, X., Ding, Q., Zhang, G., Xie, Y., Zhang, J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901808w · Cited by 74
Allosteric Interactions between the Myristate- and ATP-Site of the Abl Kinase
Iacob, R. E., Zhang, J., Gray, N. S., & Engen, J. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015929 · Cited by 74
Hiromura, K., Pippin, J. W., Blonski, M. J., Roberts, J. M., & Shankland, S. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205238 · Cited by 68
Niki, I., Ashcroft, F. M., & Ashcroft, S. J. H. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81572-8 · Cited by 67
Wang, Z., Bian, H., Bartual, S. G., Du, W., Luo, J., Zhao, H., Zhang, S., Mo, C., Zhou, Y., Xu, Y., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00140 · Cited by 67
Self-citationDDR1/E-cadherin complex regulates the activation of DDR1 and cell spreading
Wang, C., Yeh, Y.-C., & Tang, M. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00101.2009 · Cited by 60
Zhang, L., Holmes, I. P., Hochgräfe, F., Walker, S. R., Ali, N., Humphrey, E. S., Wu, J., de Silva, M., Kersten, W. J. A., Connor, T., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr3008495 · Cited by 55
Swiss, R. L., Niles, A. L., Cali, J. J., Nadanaciva, S., & Will, Y. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.05.007 · Cited by 49
Kashima, R., Redmond, P. L., Ghatpande, P., Roy, S., Kornberg, T. B., Hanke, T., Knapp, S., Lagna, G., & Hata, A. (2017) · Science Signaling · doi:10.1126/scisignal.aai8133 · Cited by 48
Self-citationNewton, P., Harrison, P., & Clulow, S. (2008) · SLAS DISCOVERY · doi:10.1177/1087057108321086 · Cited by 45
Highly Potent Cell-Permeable and Impermeable NanoLuc Luciferase Inhibitors
Walker, J. R., Hall, M. P., Zimprich, C., Robers, M. B., Duellman, S. J., Machleidt, T., Rodriguez, J., & Zhou, W. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01129 · Cited by 41
Self-citationGower, C. M., Thomas, J. R., Harrington, E. M., Murphy, J., Chang, M. E. K., Cornella‐Taracido, I., Jain, R. K., Schirle, M., & Maly, D. J. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00847 · Cited by 26
The tyrosine kinase inhibitor GNF-2 suppresses osteoclast formation and activity
Kim, H., Yoon, H., Choi, J., Lee, I. K., & Kim, S. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0713356 · Cited by 19
Cited by
Kinase inhibitors: the road ahead
Ferguson, F. M., & Gray, N. S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.21 · Cited by 1,009
Trends in kinase drug discovery: targets, indications and inhibitor design
Attwood, M. M., Fabbro, D., Sokolov, A. V., Knapp, S., & Schiöth, H. B. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00252-y · Cited by 779
Self-citationStructural basis for the action of the drug trametinib at KSR-bound MEK
Khan, Z. M., Real, A. M., Marsiglia, W. M., Chow, A., Duffy, M. E., Yerabolu, J. R., Scopton, A. P., & Dar, A. C. (2020) · Nature · doi:10.1038/s41586-020-2760-4 · Cited by 178
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2
Karim, M., Mishra, M., Lo, C.-W., Saul, S., Cagirici, H. B., Gourdelier, M., Ghita, L., Ojha, A., Tran, D. H. N., Agrawal, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61759-1 · Cited by 16
Mingione, V. R., Foda, Z. H., Paung, Y., Philipose, H., Rangwala, A. M., Shan, Y., & Seeliger, M. A. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167628 · Cited by 13
Metadata
- Authors
- Vasta, J. D., Corona, C. R., Wilkinson, J., Zimprich, C. A., Hartnett, J. R., Ingold, M. R., Zimmerman, K., Machleidt, T., Kirkland, T. A., Huwiler, K. G., Ohana, R. F., Slater, M., Otto, P., Cong, M., Wells, C. I., Berger, B.-T., Hanke, T., Glas, C., Ding, K., Drewry, D. H., Huber, K. V. M., Willson, T. M., Knapp, S., Müller, S., Meisenheimer, P. L., Fan, F., Wood, K. V., & Robers, M. B.
- Venue
- Cell Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 25
- Issue
- 2
- Pages
- 206-214.e11
- ISSN
- 2451-9448 (ISSN-L)
- 2451-9456
- OpenAlex
- W2769161116
- Cited by
- 268
- References
- 45
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.